Does Whole Blood Adsorber During CPB Reduce Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery?

Emma Hansson

Status: Completed

Conditions: Infective Endocarditis

Treatments: Device: CytoSorb

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT03945708

00001

Details and patient eligibility

About

The study aims to investigate the effect of addition of an adsorber during cardio pulmonary bypassin patients with infective endocarditis undergoing valve surgery, and if it will decrease the use of vasoactive drugs postoperatively.

Enrollment: 20 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Infected endocarditis patients undergoing heart valve surgery.
2. Age over 18 years.

Exclusion criteria

1 Declines participation

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

20 participants in 2 patient groups

Treatment

Experimental group

Description:

Addition of whole blood adsorber to CPB circuit

Treatment:

Device: CytoSorb

Control

No Intervention group

Description:

Standard treatment